Minimizing the risk of developing cerebral edema during therapy for diabetic ketoacidosis.
Carlotti
Ana P C P
AP
Bohn
Desmond
D
Kamel
Kamel S
KS
Halperin
Mitchell L
ML
D001929:Brain Edema / Q000517:prevention & control*; D002985:Clinical Protocols; D016883:Diabetic Ketoacidosis / Q000628:therapy*; D004334:Drug Administration Schedule; D045604:Extracellular Fluid / Q000502:physiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D012965:Sodium Chloride / Q000008:administration & dosage*; D017923:Sodium-Hydrogen Exchangers / Q000187:drug effects
D007004:Hypoglycemic Agents; D007328:Insulin; D017923:Sodium-Hydrogen Exchangers; D012965:Sodium Chloride